Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 2
1998 2
2000 2
2001 1
2002 1
2003 2
2004 2
2005 4
2006 8
2007 1
2008 2
2010 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

27 results
Results by year
Filters applied: . Clear all
Page 1
HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors.
Wang SE, Narasanna A, Perez-Torres M, Xiang B, Wu FY, Yang S, Carpenter G, Gazdar AF, Muthuswamy SK, Arteaga CL. Wang SE, et al. Cancer Cell. 2006 Jul;10(1):25-38. doi: 10.1016/j.ccr.2006.05.023. Cancer Cell. 2006. PMID: 16843263 Free article.
Targeting the TGF beta signaling network in human neoplasia.
Dumont N, Arteaga CL. Dumont N, et al. Cancer Cell. 2003 Jun;3(6):531-6. doi: 10.1016/s1535-6108(03)00135-1. Cancer Cell. 2003. PMID: 12842082 Free article. Review. No abstract available.
Inhibition of TGFbeta signaling in cancer therapy.
Arteaga CL. Arteaga CL. Curr Opin Genet Dev. 2006 Feb;16(1):30-7. doi: 10.1016/j.gde.2005.12.009. Epub 2005 Dec 27. Curr Opin Genet Dev. 2006. PMID: 16377175 Review.
EGF receptor mutations in lung cancer: from humans to mice and maybe back to humans.
Arteaga CL. Arteaga CL. Cancer Cell. 2006 Jun;9(6):421-3. doi: 10.1016/j.ccr.2006.05.014. Cancer Cell. 2006. PMID: 16766261 Free article. Review.
Dual role of transforming growth factor beta in mammary tumorigenesis and metastatic progression.
Muraoka-Cook RS, Dumont N, Arteaga CL. Muraoka-Cook RS, et al. Clin Cancer Res. 2005 Jan 15;11(2 Pt 2):937s-43s. Clin Cancer Res. 2005. PMID: 15701890 Free article. Review.
Transforming growth factor-beta and breast cancer: Tumor promoting effects of transforming growth factor-beta.
Dumont N, Arteaga CL. Dumont N, et al. Breast Cancer Res. 2000;2(2):125-32. doi: 10.1186/bcr44. Epub 2000 Feb 21. Breast Cancer Res. 2000. PMID: 11250702 Free PMC article. Review.
Evaluation of biological agents targeted at early-stage disease.
Guix M, Mayer IA, Meszoely IM, Arteaga CL. Guix M, et al. Breast Cancer Res. 2008;10 Suppl 4(Suppl 4):S25. doi: 10.1186/bcr2185. Epub 2008 Dec 18. Breast Cancer Res. 2008. PMID: 19128439 Free PMC article. No abstract available.
Can trastuzumab be effective against tumors with low HER2/Neu (ErbB2) receptors?
Arteaga CL. Arteaga CL. J Clin Oncol. 2006 Aug 10;24(23):3722-5. doi: 10.1200/JCO.2006.06.5268. Epub 2006 Jul 17. J Clin Oncol. 2006. PMID: 16847283 Review. No abstract available.
Oncogenic mutations regulate tumor microenvironment through induction of growth factors and angiogenic mediators.
Wang SE, Yu Y, Criswell TL, Debusk LM, Lin PC, Zent R, Johnson DH, Ren X, Arteaga CL. Wang SE, et al. Oncogene. 2010 Jun 10;29(23):3335-48. doi: 10.1038/onc.2010.112. Epub 2010 Apr 12. Oncogene. 2010. PMID: 20383197 Free PMC article.
Expression of active Akt protects against tamoxifen-induced apoptosis in MCF-7 Cells.
Shin I, Arteaga CL. Shin I, et al. IUBMB Life. 2006 Nov;58(11):664-9. doi: 10.1080/15216540601001681. IUBMB Life. 2006. PMID: 17085387 Free article.
27 results
Jump to page